Want to see APNHY full AI Analyst Report?
Aspen Pharmacare (APNHY) Financial Statements
Aspen Pharmacare Financial Overview
Aspen Pharmacare's market cap is currently $4.07B. The company's EPS TTM is $5.87; its P/E ratio is 26.51; and it has a dividend yield of 1.45%. Aspen Pharmacare is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 34.14B | $ 43.36B | $ 44.71B | $ 40.71B | $ 38.61B |
| Gross Profit | $ 13.76B | $ 19.13B | $ 19.42B | $ 18.41B | $ 18.31B |
| Operating Income | $ 5.29B | $ 1.44B | $ 7.00B | $ 7.82B | $ 8.67B |
| EBITDA | $ 7.16B | $ 3.62B | $ 9.90B | $ 10.72B | $ 10.45B |
| Net Income | $ 2.59B | $ -1.08B | $ 4.40B | $ 5.23B | $ 6.49B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.87B | $ 6.41B | $ 12.34B | $ 10.91B | $ 6.18B |
| Total Assets | $ 107.41B | $ 135.89B | $ 139.16B | $ 134.28B | $ 111.38B |
| Total Debt | $ 15.44B | $ 36.12B | $ 36.46B | $ 29.28B | $ 22.25B |
| Net Debt | $ -425.58M | $ 29.71B | $ 24.12B | $ 18.37B | $ 16.06B |
| Total Liabilities | $ 27.68B | $ 51.00B | $ 54.29B | $ 48.05B | $ 40.43B |
| Stockholders' Equity | $ 79.73B | $ 84.89B | $ 84.86B | $ 86.24B | $ 70.94B |
| Cash Flow | |||||
| Free Cash Flow | $ 4.63B | $ 104.00M | $ 690.00M | $ 2.34B | $ 2.68B |
| Operating Cash Flow | $ 6.73B | $ 5.16B | $ 6.22B | $ 5.52B | $ 5.37B |
| Investing Cash Flow | $ 23.83B | $ -5.22B | $ -9.47B | $ -3.42B | $ -2.16B |
| Financing Cash Flow | $ -20.86B | $ -162.00M | $ 3.62B | $ -420.00M | $ -4.68B |
Currency in ZAR